Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mediolanum farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10918
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mediolanum farmaceutici SpA (Mediolanum) is a developer and supplier of pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas, which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolics. It offers products for neuropsychiatric area, which include anxiety, depression and migraine. Mediolanum provides products for vascular area which include peripheral obliterant arteriopathy and chronic venous insufficiency. The company invests in various patents and projects in areas of endocrinology, rheumatoid arthritis, vaccines for prostate and kidney cancer, and others. Mediolanum is headquartered in Milan, Italy.

Mediolanum farmaceutici SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mediolanum Farmaceutici Acquires GX301, Therapeutic Vaccine For Treatment Of Cancer, From Genovax 10
Partnerships 12
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Licensing Agreements 13
Mediolanum Enters into Research & Development Cooperation and Licensing Agreement with Apeptico 13
Asset Transactions 14
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 14
Mediolanum farmaceutici SpA – Key Competitors 15
Mediolanum farmaceutici SpA – Key Employees 16
Mediolanum farmaceutici SpA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Key Facts 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediolanum farmaceutici SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mediolanum Farmaceutici Acquires GX301, Therapeutic Vaccine For Treatment Of Cancer, From Genovax 10
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Mediolanum Enters into Research & Development Cooperation and Licensing Agreement with Apeptico 13
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 14
Mediolanum farmaceutici SpA, Key Competitors 15
Mediolanum farmaceutici SpA, Key Employees 16
Mediolanum farmaceutici SpA, Subsidiaries 17

List of Figures
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • CriticalControl Solutions Corp. (CCZ):企業概要、財務及び戦略的SWOT分析
    Summary CriticalControl Solutions Corp. (CriticalControl) is a technology company. It offers solutions to manage mission-critical information to the clients. It builds, operates and supports applications that gather, manage and disseminate information in government and the energy sector. It provides …
  • Black Ridge Oil & Gas Inc (ANFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Ridge Oil & Gas Inc (Black Ridge), formerly Ante5 Inc is an oil and gas company that acquires, develops, explores and produces crude oil and natural gas properties. The company's projects are located in Bakken and three Forks trends in Montana and North Dakota. It acquires gas assets t …
  • Tamron Co., Ltd. (7740):企業財務及び戦略的SWOT分析
    Summary Tamron Co., Ltd. (Tamron) is an optical equipment company that manufactures a range of precision optical equipment. The company’s products include interchangeable lenses for digital SLR camera; interchangeable lenses for non-reflex type camera; camcorder lenses; digital still camera lenses; …
  • Janssen Diagnostics LLC:企業のM&A・提携動向(医療機器分野)
    Summary Janssen Diagnostics LLC (Janssen) is a medical device company that develops and markets diagnostics products and solutions for the healthcare markets. The company offers its products for the treatment of infectious diseases, neuroscience, oncology, cardiovascular diseases and immunology. Its …
  • MPC Ferrostaal GmbH:企業のM&A・提携動向(発電分野)
    Summary MPC Ferrostaal GmbH (Ferrostaal) is a global provider of industrial services in plant construction and engineering. The company acts as a technology-independent system integrator. It offers development and management of projects, financial planning and construction services for turnkey indus …
  • MPI Research Inc:企業のM&A・提携動向(医療分野)
    Summary MPI Research Inc (MPI) is a contract research company that provides preclinical and early clinical research services. The company’s services include drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services, medical device evaluation, trans …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cegedim SA (CGM):企業財務及び戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is an information technology company that offers technical services in healthcare sectors. The company offers services for pharmaceutical companies, healthcare professionals and health insurers. It offers pharmaceutical services which include insurer solutions, promotion …
  • Alaska Communications Systems Group, Inc. (ALSK):企業の財務及び戦略的SWOT分析
    Summary Alaska Communications Systems Group, Inc. (ACS) is an integrated communications service provider that provides telecommunications and information technology services to its customers. The company offers internet services, data networks, voice services, wireless mobility, IT managed services, …
  • South Carolina Electric & Gas Company:電力:M&Aディール及び事業提携情報
    Summary South Carolina Electric & Gas Company (SCE&G), a subsidiary of Scana Corporation, is an energy utility that generates, transmits, distributes and trades of electricity; and purchases, transports and sells natural gas. The company generates electricity through diverse energy sources such as n …
  • Flint Energy Services Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Flint Energy Services Ltd. Merg …
  • Aetna Inc:企業のM&A・提携・投資分析
    Aetna Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aetna Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Toys “R” Us, Inc.: Retailing:企業概要およびSWOT分析
    Summary Canadean's "Toys "R" Us, Inc.: Retailing - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, me …
  • Prosper Marketplace, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Prosper Marketplace, Inc. Merge …
  • PolyPid Ltd:企業のM&A・提携動向(医療機器分野)
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs infection treatment and prevention. The company’s product portfolio comprises BonyPid-1000 and BonyPid-500 which is a bone graft substitute based product intended for filling …
  • Connell Limited Partnership:企業の戦略・SWOT・財務分析
    Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • InvenSense, Inc. (INVN):企業概要、財務及び戦略的SWOT分析
    Summary InvenSense, Inc. (InvenSense) is a technology company. The company offers motiontracking sensor system on chip and sound solutions for consumer electronic devices. Its products include nine-axis MEMS motion motiontracking device, six axis MEMS motion processor-3-axis gyroscope and 3-axis acc …
  • Rajshree Sugars & Chemicals Limited (RAJSREESUG):企業概要、財務及び戦略的SWOT分析
    Summary Rajshree Sugars & Chemicals Limited (RSCL) is a sugar product company. The company works through its businesses in sugar, green power, alcohol production and RSCL bio-products. Its alcohol products include rectified spirit, anhydrous alcohol and extra neutral alcohol. RSCL offers bio-product …
  • Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報
    Summary Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imagin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆